21.84 USD
+0.33 (+1.53%)
21.84 USD
0 (0%)
TBRG gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. There are concerns on the financial health of TBRG while its profitability can be described as average. TBRG may be a bit undervalued, certainly considering the very reasonable score on growth
1. Profitability
1.1 Basic Checks
TBRG had positive earnings in the past year.
In the past year TBRG had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: TBRG reported negative net income in multiple years.
Each year in the past 5 years TBRG had a positive operating cash flow.
1.2 Ratios
With a decent Return On Assets value of 1.36%, TBRG is doing good in the industry, outperforming 80.00% of the companies in the same industry.
TBRG has a Return On Equity of 3.01%. This is in the better half of the industry: TBRG outperforms 80.00% of its industry peers.
TBRG has a better Return On Invested Capital (5.72%) than 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.36% | ||
| ROE | 3.01% | ||
| ROIC | 5.72% |
ROA(3y)-3.89%
ROA(5y)-0.55%
ROE(3y)-9.64%
ROE(5y)-2.79%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
TBRG's Profit Margin of 1.55% is fine compared to the rest of the industry. TBRG outperforms 77.14% of its industry peers.
The Operating Margin of TBRG (7.15%) is better than 77.14% of its industry peers.
In the last couple of years the Operating Margin of TBRG has declined.
TBRG has a worse Gross Margin (53.16%) than 62.86% of its industry peers.
In the last couple of years the Gross Margin of TBRG has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.15% | ||
| PM (TTM) | 1.55% | ||
| GM | 53.16% |
OM growth 3Y-40.35%
OM growth 5Y-26.39%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.4%
GM growth 5Y-0.64%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so TBRG is destroying value.
Compared to 1 year ago, TBRG has more shares outstanding
The number of shares outstanding for TBRG has been increased compared to 5 years ago.
Compared to 1 year ago, TBRG has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.09 indicates that TBRG is not a great score, but indicates only limited risk for bankruptcy at the moment.
TBRG has a Altman-Z score of 2.09. This is comparable to the rest of the industry: TBRG outperforms 60.00% of its industry peers.
The Debt to FCF ratio of TBRG is 7.86, which is on the high side as it means it would take TBRG, 7.86 years of fcf income to pay off all of its debts.
TBRG has a Debt to FCF ratio of 7.86. This is comparable to the rest of the industry: TBRG outperforms 54.29% of its industry peers.
TBRG has a Debt/Equity ratio of 0.89. This is a neutral value indicating TBRG is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.89, TBRG is doing worse than 85.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.89 | ||
| Debt/FCF | 7.86 | ||
| Altman-Z | 2.09 |
ROIC/WACC0.56
WACC10.25%
2.3 Liquidity
A Current Ratio of 1.91 indicates that TBRG should not have too much problems paying its short term obligations.
TBRG's Current ratio of 1.91 is in line compared to the rest of the industry. TBRG outperforms 42.86% of its industry peers.
A Quick Ratio of 1.90 indicates that TBRG should not have too much problems paying its short term obligations.
TBRG has a Quick ratio (1.90) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.91 | ||
| Quick Ratio | 1.9 |
3. Growth
3.1 Past
TBRG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 266.00%, which is quite impressive.
The earnings per share for TBRG have been decreasing by -40.46% on average. This is quite bad
TBRG shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -16.88%.
Measured over the past years, TBRG shows a small growth in Revenue. The Revenue has been growing by 4.53% on average per year.
EPS 1Y (TTM)266%
EPS 3Y-58.61%
EPS 5Y-40.46%
EPS Q2Q%519.05%
Revenue 1Y (TTM)-16.88%
Revenue growth 3Y6.89%
Revenue growth 5Y4.53%
Sales Q2Q%2.72%
3.2 Future
The Earnings Per Share is expected to grow by 134.53% on average over the next years. This is a very strong growth
Based on estimates for the next years, TBRG will show a small growth in Revenue. The Revenue will grow by 3.67% on average per year.
EPS Next Y1149.5%
EPS Next 2Y229.6%
EPS Next 3Y134.53%
EPS Next 5YN/A
Revenue Next Year3.21%
Revenue Next 2Y3.62%
Revenue Next 3Y3.67%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 11.93 indicates a reasonable valuation of TBRG.
Compared to the rest of the industry, the Price/Earnings ratio of TBRG indicates a rather cheap valuation: TBRG is cheaper than 94.29% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.19, TBRG is valued rather cheaply.
A Price/Forward Earnings ratio of 10.58 indicates a reasonable valuation of TBRG.
TBRG's Price/Forward Earnings ratio is rather cheap when compared to the industry. TBRG is cheaper than 91.43% of the companies in the same industry.
TBRG's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.92.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.93 | ||
| Fwd PE | 10.58 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, TBRG is valued cheaper than 85.71% of the companies in the same industry.
TBRG's Price/Free Cash Flow ratio is rather cheap when compared to the industry. TBRG is cheaper than 88.57% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.69 | ||
| EV/EBITDA | 9.07 |
4.3 Compensation for Growth
TBRG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
TBRG's earnings are expected to grow with 134.53% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.01
PEG (5Y)N/A
EPS Next 2Y229.6%
EPS Next 3Y134.53%
5. Dividend
5.1 Amount
TBRG does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
21.84
+0.33 (+1.53%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners70.3%
Inst Owner Change0%
Ins Owners3.34%
Ins Owner Change6.51%
Market Cap327.82M
Revenue(TTM)349.88M
Net Income(TTM)5.42M
Analysts76.36
Price Target23.05 (5.54%)
Short Float %5.47%
Short Ratio7.51
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)103.24%
Min EPS beat(2)83.56%
Max EPS beat(2)122.91%
EPS beat(4)3
Avg EPS beat(4)34.96%
Min EPS beat(4)-87.3%
Max EPS beat(4)122.91%
EPS beat(8)5
Avg EPS beat(8)-2.39%
EPS beat(12)7
Avg EPS beat(12)-5.28%
EPS beat(16)9
Avg EPS beat(16)-3.09%
Revenue beat(2)0
Avg Revenue beat(2)-2.17%
Min Revenue beat(2)-3.3%
Max Revenue beat(2)-1.05%
Revenue beat(4)1
Avg Revenue beat(4)-0.92%
Min Revenue beat(4)-3.3%
Max Revenue beat(4)1.51%
Revenue beat(8)2
Avg Revenue beat(8)-0.82%
Revenue beat(12)2
Avg Revenue beat(12)-1.3%
Revenue beat(16)5
Avg Revenue beat(16)-0.47%
PT rev (1m)0%
PT rev (3m)-8.69%
EPS NQ rev (1m)-0.33%
EPS NQ rev (3m)-2.77%
EPS NY rev (1m)0%
EPS NY rev (3m)17.11%
Revenue NQ rev (1m)-0.16%
Revenue NQ rev (3m)-1.01%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.08%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.93 | ||
| Fwd PE | 10.58 | ||
| P/S | 0.94 | ||
| P/FCF | 15.69 | ||
| P/OCF | 8.54 | ||
| P/B | 1.82 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.07 |
EPS(TTM)1.83
EY8.38%
EPS(NY)2.06
Fwd EY9.45%
FCF(TTM)1.39
FCFY6.37%
OCF(TTM)2.56
OCFY11.71%
SpS23.31
BVpS12.02
TBVpS-6.93
PEG (NY)0.01
PEG (5Y)N/A
Graham Number22.24
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.36% | ||
| ROE | 3.01% | ||
| ROCE | 7.24% | ||
| ROIC | 5.72% | ||
| ROICexc | 6.07% | ||
| ROICexgc | 47.77% | ||
| OM | 7.15% | ||
| PM (TTM) | 1.55% | ||
| GM | 53.16% | ||
| FCFM | 5.97% |
ROA(3y)-3.89%
ROA(5y)-0.55%
ROE(3y)-9.64%
ROE(5y)-2.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-34.77%
ROICexgc growth 5Y-16.72%
ROICexc growth 3Y-36.47%
ROICexc growth 5Y-24.96%
OM growth 3Y-40.35%
OM growth 5Y-26.39%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.4%
GM growth 5Y-0.64%
F-Score8
Asset Turnover0.88
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.89 | ||
| Debt/FCF | 7.86 | ||
| Debt/EBITDA | 3.13 | ||
| Cap/Depr | 66.1% | ||
| Cap/Sales | 5% | ||
| Interest Coverage | 1.87 | ||
| Cash Conversion | 74.56% | ||
| Profit Quality | 385.36% | ||
| Current Ratio | 1.91 | ||
| Quick Ratio | 1.9 | ||
| Altman-Z | 2.09 |
F-Score8
WACC10.25%
ROIC/WACC0.56
Cap/Depr(3y)79.13%
Cap/Depr(5y)69.66%
Cap/Sales(3y)6.13%
Cap/Sales(5y)4.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)266%
EPS 3Y-58.61%
EPS 5Y-40.46%
EPS Q2Q%519.05%
EPS Next Y1149.5%
EPS Next 2Y229.6%
EPS Next 3Y134.53%
EPS Next 5YN/A
Revenue 1Y (TTM)-16.88%
Revenue growth 3Y6.89%
Revenue growth 5Y4.53%
Sales Q2Q%2.72%
Revenue Next Year3.21%
Revenue Next 2Y3.62%
Revenue Next 3Y3.67%
Revenue Next 5YN/A
EBIT growth 1Y432.85%
EBIT growth 3Y-36.24%
EBIT growth 5Y-23.05%
EBIT Next Year161.45%
EBIT Next 3Y48.17%
EBIT Next 5YN/A
FCF growth 1Y380.13%
FCF growth 3Y-29.73%
FCF growth 5Y-20.85%
OCF growth 1Y147.92%
OCF growth 3Y-12.4%
OCF growth 5Y-5.94%
TRUBRIDGE INC / TBRG FAQ
What is the ChartMill fundamental rating of TRUBRIDGE INC (TBRG) stock?
ChartMill assigns a fundamental rating of 4 / 10 to TBRG.
What is the valuation status for TBRG stock?
ChartMill assigns a valuation rating of 9 / 10 to TRUBRIDGE INC (TBRG). This can be considered as Undervalued.
Can you provide the profitability details for TRUBRIDGE INC?
TRUBRIDGE INC (TBRG) has a profitability rating of 4 / 10.
What is the financial health of TRUBRIDGE INC (TBRG) stock?
The financial health rating of TRUBRIDGE INC (TBRG) is 3 / 10.
Is the dividend of TRUBRIDGE INC sustainable?
The dividend rating of TRUBRIDGE INC (TBRG) is 0 / 10 and the dividend payout ratio is 0%.